Updated Nov 4, 2026FDA and CMS public dataIndependent · free · not health advice
GxRadar
Drugs/Pantoprazole DR 40 mg tablet
Stomach acid

Pantoprazole DR 40 mg tablet

Public data on pantoprazole from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.

$0.0367
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-39%
change over five years
peak $0.1306 in 2015-04
42
approved generic applications (ANDAs) on record for Pantoprazole Sodium
31 with a product still marketed · first 2007
Not listed
in FDA's current shortage list
no matching FDA shortage entries

NADAC per unit, monthly

PANTOPRAZOLE SOD DR 40 MG TAB
Show as table
MonthNADAC per unit ($)
2013-110.08623
2014-020.11904
2014-050.09646
2014-080.12084
2014-110.10323
2015-020.12382
2015-050.12152
2015-080.10659
2015-110.09023
2016-020.08264
2016-050.08173
2016-080.07788
2016-110.07808
2017-020.06911
2017-050.06674
2017-080.06915
2017-110.07013
2018-020.06793
2018-050.05759
2018-080.05910
2018-110.05965
2019-020.05965
2019-050.05950
2019-080.06793
2019-110.07841
2020-020.06626
2020-050.06382
2020-080.06248
2020-110.05987
2021-020.05958
2021-050.06618
2021-080.06288
2021-110.06060
2022-020.05946
2022-050.06362
2022-080.06139
2022-110.06175
2023-020.05753
2023-050.05468
2023-080.05530
2023-110.05326
2024-020.05404
2024-050.04621
2024-080.04818
2024-110.04394
2025-020.03612
2025-050.03765
2025-080.03813
2025-110.03609
2026-020.03576
2026-050.03576
2026-080.03560
2026-110.03675

Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.

Recall records mentioning pantoprazole

openFDA enforcement records, by year reported.

20262
20234
20223
20212
20201
20192
20182
20172
20161
20151

27 records since 2012. A record is one product or lot, not one recall event. Combination products that contain pantoprazole are included.

What these numbers mean

NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.

Most recent recall records

Class IIOngoing
Pantoprazole sodium in 0.9% sodium chloride injection
Reason category: cGMP deviations
FDA recall number D-0812-2026
Class IIOngoing
Pantoprazole delayed-release tablets
Reason category: Other
FDA recall number D-0484-2026
Class IITerminated
Pantoprazole sodium for injection
Reason category: Sterility / contamination
FDA recall number D-1148-2023
Class IICompleted
Pantoprazole product
Reason category: cGMP deviations
FDA recall number D-0540-2023
Class IIOngoing
Pantoprazole delayed release tablets
Reason category: cGMP deviations
FDA recall number D-0530-2023

Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.

Articles that mention pantoprazole

6 GxRadar articles cite or discuss this drug.

OMEPRAZOLE · NADAC
Price histories · Data story · 6 min

What pharmacies paid for omeprazole, pantoprazole and famotidine

Pharmacy costs for generic omeprazole and pantoprazole fell by more than half from 2013 to 2026. Prescription famotidine jumped 68 percent after the 2020 ranitidine withdrawal, then fell back below its 2013 level.

PRICE INDEX · 2014 = 100
Price histories · Data story · 5 min

What pharmacies pay for a month of common generics

Thirty tablets of each of the 10 most-used generics we track cost pharmacies $35.70 in January 2014 and $8.80 in October 2026. That is acquisition cost, and the rest of the price sits on top of it.

Generic or brand · Explainer · 6 min

Extended-release, delayed-release and immediate-release pills, and how FDA judges their generics

ER, XL, DR and the rest describe how a pill lets go of its drug. What the formulations are, how FDA tests generic copies of each, what the Orange Book codes say, and what our recall data show.

PRICE INDEX · 2014 = 100
Price histories · Data story · 6 min

The generics that cost pharmacies more than they did in 2014

Most generics in GxRadar's 47-drug basket got cheaper. Seven cost pharmacies more than in January 2014, led by furosemide at 2.8 times its 2014 price. What federal cost and shortage data show, drug by drug.

PRICE INDEX · 2014 = 100
Benchmarks & how prices are set · Data story · 6 min

The brand-generic gap in NADAC

In CMS's Oct. 28, 2026 cost file, brand tablets and capsules cost pharmacies a median 21 times the matching generic. For amlodipine the multiple was 857. Where the gap is widest, and where it nearly closes.

Sourcing & manufacturing · Explainer · 6 min

India's place in the US generic drug supply

What FDA and USP data show about how much US generic medicine comes from India, how FDA inspects Indian plants, and what the figures cannot tell you.